Product Details
C-Reactive Protein / Serum Amyloid Protein Combined (CRP/SAA)
Performance Index
Combined detection of CRP and SAA
White blood cell (WBC) + C-reactive protein (CRP) + serum amyloid A
(SAA) "three new routine detection" was proposed by many famous
pediatric experts based on the clinical value of SAA detection in
the diagnosis of infants. In recent years, infection has been
widely used and recognized. Results The total positive rate of SAA
in various inflammatory diseases was 8.54% higher than that of CRP.
Combined SAA and CRP tests allow for more accurate diagnosis of
infection types and monitoring of infectious disease progression.
Clinical significance of CRP / SAA
SAA normal CRP was normal | SAA normal Elevated CRP | SAA increased CRP was normal | SAA increased Elevated CRP |
Consider non-infectious factors | The disease is improving | Consider virus infection | Consider bacterial infection |
Treatment or monitoring was continued until SAA and CRP returned to
normal, depending on the patient's clinical symptoms. | Based on clinical findings, his SAA and CRP returned to normal. | Antiviral therapy; Both SAA and CRP have been monitored to return
to normal or change the treatment plan. | After antibiotic treatment, we monitored SAA and CRP to normalize
or change the treatment plan |
CRP / SAA performance index
Detection range | sample size | Sample type | Test time |
CRP | SAA | 5μl | Whole blood / serum / plasma | 3min |
0.5~200mg/L | 5~200mg/L |
Clinical comparison of CRP / SAA
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
Company Profile
Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is
located in Dingluan Industrial Zone, Changyuan City, Henan
Province. The company covers an area of about 100 acres and the
initial investment is about 200 million yuan. The company has a
scientific and complete management system, a purification workshop
of national standards, and a fully functional inspection center. On
this basis, the company will continue to invest in research and
development, accumulate technical strength, update manufacturing
equipment, improve production technology, improve inspection
technology, improve product quality, and provide customers with
safe and effective in vitro diagnostic products.
Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, immune series,
microbial series and other reagents and supporting instruments.
The company has always adhered to the core concept of “fast and
accurate, living up to life”, committed to providing society with
excellent products and services, and contributing to the cause of
human health.